Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06795529 · ClinicalTrials.gov registry record · NA
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
A NA study of Metastatic Breast Cancer, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 3
- Study locations
NCT06795529: Recruiting NA study of Metastatic Breast Cancer, sponsored by Massachusetts General Hospital.
NCT06795529 is a NA study of Metastatic Breast Cancer that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 400 participants, above the 202-participant average among 139 other Metastatic Breast Cancer trials with a reported enrollment target (98% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06795529, a NA study of Metastatic Breast Cancer, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 3
- Study locations
Study Summary
Many people living with metastatic breast cancer face challenging symptoms and frequent medical visits. At the same time, conversations about personal goals, values, and preferences for care may not always happen as early or as often as patients and families would like. This multi-site study will test the effectiveness of a five-session palliative care program, designed specifically for people with metastatic breast cancer and their caregivers, to strengthen communication with clinicians about what matters most in their care. The study aims to inform how palliative care services can be delivered in a more timely, personalized, and scalable way for people living with advanced cancers who have long disease trajectories, such as metastatic breast cancer.
Primary Outcome
To compare proportions of patients with clinician-documented end-of-life care preferences in the electronic health record by last follow-up time point or date of death between study groups.
Conditions Studied
Interventions
- OTHER Enhanced Usual Care
- OTHER Palliative Care Intervention, "TARGET-PC"
Study Locations (3)
Massachusetts
- Massachusetts General Hospital - Boston
North Carolina
- Duke University - Durham
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2030-03-31 |
| Phase | NA |
What NCT06795529 shows while recruiting
NCT06795529 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, above the 202-participant average among 139 other Metastatic Breast Cancer trials with a reported enrollment target (98% higher).
The record links to 1 condition, with Metastatic Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Usual Care is the first listed.
NCT06795529 reports a single indexed study location in Massachusetts, North Carolina, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06795529 about?
NCT06795529 is a clinical study titled "Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer". Many people living with metastatic breast cancer face challenging symptoms and frequent medical visits. At the same time, conversations about personal goals, values, and preferences for care may not always happen as early or as often as patients and families would like. This multi-site study will te...
What is the current status of trial NCT06795529?
This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2025-10-01. Estimated completion is 2030-03-31.
What conditions does trial NCT06795529 study?
This clinical trial studies the following conditions: Metastatic Breast Cancer.
What interventions are being tested in trial NCT06795529?
The interventions under investigation include: Enhanced Usual Care (OTHER), Palliative Care Intervention, "TARGET-PC" (OTHER).
Who is sponsoring clinical trial NCT06795529?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06795529 being conducted?
This trial has 3 study locations across Massachusetts, North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metastatic Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06795529's enrollment target sits among peer trials
400 17th of 139 higher than 123 of 139 other Metastatic Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Metastatic Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer
RECRUITING · NA
-
Adaptation of a Values Assessment Tool
RECRUITING · NA
-
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
RECRUITING · NA
-
Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise
RECRUITING · NA
-
Enhancing Access to Supportive Services for Women of Color With Metastatic Breast Cancer
RECRUITING · NA
-
Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI